List of works - Diego Ferone

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms.

scientific article

Effect of octreotide pretreatment on surgical outcome in acromegaly

scientific article published on 01 October 1997

Effect of different dopaminergic agents in the treatment of acromegaly

scientific article published on 01 February 1997

Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly

scientific article published on 01 November 2012

Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Colon and Rectum Tumour/Carcinoma

article

Peptide receptor therapies in neuroendocrine tumors.

scientific article published on April 2009

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms

scientific article published on 05 January 2016

Acromegaly

scientific article published on 01 September 1997

Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient

scientific article published on 20 February 2007

Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg).

scientific article

High prevalence of vitamin D deficiency and its association with left ventricular dilation: an echocardiography study in elderly patients with chronic heart failure.

scientific article published on 15 April 2010

Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study.

scientific article

Managing Cushing's disease: the state of the art.

scientific article published on 11 January 2014

Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency

scientific article

Prostatic Hyperplasia: An Unknown Feature of Acromegaly

scientific article published on March 1, 1998

Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly

scientific article published on 01 January 1999

Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses.

scientific article published on 13 July 2011

Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly.

scientific article published in July 1997

Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly

scientific article published on 01 September 1993

Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine

scientific article published on 01 March 1998

Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors.

scientific article published on 2 August 2016

Somatostatin receptor ligands in the treatment of acromegaly

scientific article published on 7 February 2017

Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study.

scientific article published on July 2012

Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.

scientific article published on April 2000

Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence.

scientific article

Reversibility of Joint Thickening in Acromegalic Patients: An Ultrasonography Study

scientific article published on June 1, 1998

ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Biochemical Markers

scientific article published on 08 April 2017

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.

scientific article

The metabolic profile in active acromegaly is gender-specific.

scientific article

Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months.

scientific article

Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogs

scientific article published on 26 March 2012

Diffuse endocrine system, neuroendocrine tumors and immunity: what's new?

scientific article published on 12 January 2012

Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures

article

Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.

scientific article published on 27 September 2010

Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies.

scientific article published on 27 October 2013

Novel chimeric somatostatin analogs: facts and perspectives.

scientific article published on April 2007

Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.

scientific article

Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.

scientific article

Zebrafish as an innovative model for neuroendocrine tumors

scientific article published on 21 January 2014

Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor

scientific article published on 25 August 2015

Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects

scientific article published on 01 June 1999

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

scientific article published on 20 September 2016

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors

scientific article published on 2 March 2017

Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population

scientific article published on 01 May 2008

β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly.

scientific article published on 29 October 2013

Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro

scientific article published on 01 April 2000

Cost-of-illness study in acromegalic patients in Italy

scientific article published on 01 December 2004

Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.

scientific article published on June 2006

Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease

scientific article published on 01 July 2000

Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.

scientific article

List of works by Diego Ferone

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms.

Effect of octreotide pretreatment on surgical outcome in acromegaly

Effect of different dopaminergic agents in the treatment of acromegaly

Immunoreactivity score using an anti-sst2A receptor monoclonal antibody strongly predicts the biochemical response to adjuvant treatment with somatostatin analogs in acromegaly

Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumours: Well-Differentiated Colon and Rectum Tumour/Carcinoma

Peptide receptor therapies in neuroendocrine tumors.

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms

Acromegaly

Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient

Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg).

High prevalence of vitamin D deficiency and its association with left ventricular dilation: an echocardiography study in elderly patients with chronic heart failure.

Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study.

Managing Cushing's disease: the state of the art.

Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency

Prostatic Hyperplasia: An Unknown Feature of Acromegaly

Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly

Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses.

Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly.

Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly

Cabergoline treatment rapidly improves gonadal function in hyperprolactinemic males: a comparison with bromocriptine

Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors.

Somatostatin receptor ligands in the treatment of acromegaly

Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study.

Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide.

Therapy of endocrine disease: outcomes in patients with Cushing's disease undergoing transsphenoidal surgery: systematic review assessing criteria used to define remission and recurrence.

Reversibility of Joint Thickening in Acromegalic Patients: An Ultrasonography Study

ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Biochemical Markers

Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database.

The metabolic profile in active acromegaly is gender-specific.

Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months.

Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogs

Diffuse endocrine system, neuroendocrine tumors and immunity: what's new?

Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures

Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines.

Neuroendocrine tumors: insights into innovative therapeutic options and rational development of targeted therapies.

Novel chimeric somatostatin analogs: facts and perspectives.

Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.

Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.

Zebrafish as an innovative model for neuroendocrine tumors

Grade Increases in Gastroenteropancreatic Neuroendocrine Tumor Metastases Compared to the Primary Tumor

Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects

T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors

Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population

β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly.

Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro

Cost-of-illness study in acromegalic patients in Italy

Neuroendocrine-immune interactions: the role of cortistatin/somatostatin system.

Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease

Assessment of disease activity in acromegaly by means of a single blood sample: comparison of the 120th minute postglucose value with spontaneous GH secretion and with the IGF system.